-
Cepharanthine in Endometriosis: Evidence and Limits
2026-09-04
A 2026 study evaluated the biscoclaurine alkaloid Cepharanthine across endometriotic stromal cells, patient-derived endometrial organoids, and a murine peritoneal model. The concordant findings connect lesion-growth suppression with G0/G1 arrest, DNA damage, impaired repair, and mitochondria-linked apoptosis, while also defining the preclinical evidence gaps before clinical translation.
-
Sulfo-NHS-Biotin for Protein Labeling
2026-09-04
Sulfo-NHS-Biotin is a water-soluble, amine-reactive protein labeling reagent for covalent biotinylation of lysine side chains and N-terminal amines. Its membrane-impermeant behavior supports cell surface protein labeling, while its biotin handle supports affinity chromatography biotinylation and immunoprecipitation workflows.
-
Uridine and the Next Era of RNA-Guided Insertion
2026-09-03
RNA-mediated genome engineering is shifting transgene delivery from DNA-centric methods toward programmable, potentially lower-mutagenesis workflows. This article examines how Uridine, Trisodium Salt can support translational RNA metabolism studies and PRINT-oriented research while clearly separating biochemical utility from evidence established in the reference study.
-
Amine Chemistry Predicts Lung-Selective mRNA Delivery
2026-09-03
The reference study combines a systematically varied polymer-micelle library with SHAP and multitask Gaussian Process modeling to show that amine chemistry, particularly mRNA-binding behavior, predicts delivery, viability, and protein expression. Its results identify a primary/secondary amine amphiphile with strong in vitro performance and lung-selective activity in vivo, while also showing why binding strength must be balanced against productive intracellular release.
-
Cy5-UTP RNA Labeling: Workflow & Troubleshooting
2026-09-02
Cy5-UTP enables direct, far-red visualization of RNA produced by T7 in vitro transcription, supporting FISH, transcriptomic probes, and dual-color expression arrays. This practical guide covers incorporation design, cleanup, assay controls, storage, and troubleshooting while showing how RNA formulation research can inform better analytical workflows.
-
GlioME Organoids Preserve the Glioma Microenvironment
2026-09-02
The reference study introduces GlioME, a patient-derived glioma organoid model designed to retain tumor-associated cellular interactions, resident immune cells, and key genetic and epigenetic features of the original tumor. By combining transcriptomic, genomic, methylation, imaging, and flow-cytometric analyses, the work establishes a more biologically representative platform for drug screening and therapeutic evaluation.
-
BFH772 (VEGFR2 inhibitor) Protocol Guide
2026-09-01
BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled kinase, cellular angiogenesis, and tumor angiogenesis research where organic-solvent compatibility is acceptable. It is not an appropriate choice for water-based formulations or experiments requiring broad-spectrum kinase inhibition, and its product-dossier potency should not be treated as a cellular or in vivo dose.
-
Cy5-UTP for RNA Probe Synthesis and FISH
2026-09-01
Cy5-UTP enables direct, far-red visualization of RNA generated by T7 in vitro transcription, making it useful for FISH, dual-color expression arrays, and RNA process development. This guide connects practical labeling workflows with circRNA vaccine research while separating analytical tracking from functional vaccine manufacture.
-
Benzyl-activated Streptavidin Magnetic Beads K1301
2026-08-31
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide a magnetic format for capturing biotinylated peptides, proteins, antibodies, oligonucleotides, and other targets from complex samples. They are appropriate for biotin-dependent purification and assay workflows, but not for direct capture of nonbiotinylated analytes unless an indirect biotinylation strategy is introduced and validated.
-
HyperScribe: ARCA Capped mRNA Synthesis Kit
2026-08-31
The HyperScribe All in One mRNA Synthesis Kit enables streamlined ARCA-capped and polyadenylated RNA production. This guide connects RNA architecture, quality control, and assay selection to lessons from spleen-targeted neoantigen mRNA vaccine research.
-
PID1, Oxysterols, and Antitumor Macrophage Immunity
2026-08-30
The reference study identifies PID1 as an immunometabolic checkpoint in tumor-associated macrophages: its loss increases LDL uptake, cholesterol-derived oxidative stress, and production of oxysterols that suppress mTOR–STAT6 signaling. This reprograms macrophages toward an antitumor state and enhances CD8+ T cell surveillance, including in combination with 5-fluorouracil.
-
AO/PI Double Staining Kit: Practical Guide
2026-08-29
The AO/PI Double Staining Kit (SKU K2238) provides a rapid fluorescent cell viability assay that separates viable, apoptotic-like, and membrane-compromised cell populations by combining Acridine Orange and Propidium Iodide staining. It is best suited to prepared cell suspensions or dispersed cells and should not be treated as a standalone method for tissue imaging or definitive cell-death pathway assignment.
-
Cannabidiol in Orofacial Pain: Mechanistic Insights
2026-08-28
This reference study shows that cannabidiol reduces both inflammatory nociception and pain-associated affective and cognitive disturbances in mouse models. Its main contribution is a multilevel mechanistic framework linking peripheral CB2-associated inflammatory control, central CB1-related endocannabinoid signaling, and serotonin dynamics in the central amygdala.
-
Annexin V-Cy5 Apoptosis Kit for Microglia
2026-08-28
Use the Annexin V-Cy5 Apoptosis Kit to separate genuine phosphatidylserine exposure from lysosomal stress, hypertrophy, and impaired cargo digestion in microglia models. Its rapid fluorescence workflow supports both population-level flow cytometry apoptosis detection and spatial fluorescence microscopy apoptosis analysis.
-
URB597 for Reliable FAAH Assays
2026-08-27
A scenario-based guide to using URB597 (SKU A4372; KDS-4103) in cell-based viability, proliferation, cytotoxicity, and endocannabinoid experiments. It connects assay design, solvent control, protocol handling, data interpretation, and vendor selection to reported FAAH potency and formulation data.